# Efficacy and Safety of Neo-CRT Followed Surgery Compared With Definitive CRT in Patients With Initial Unresectable ESO

> **NCT04137679** · PHASE2 · UNKNOWN · sponsor: **Tianjin Medical University Cancer Institute and Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Unresectable Esophageal Cancer

## Interventions

- **RADIATION:** Definitive Radiochemotherapy
- **PROCEDURE:** Neoadjuvant Radiochemotherapy followed by surgery

## Key facts

- **NCT ID:** NCT04137679
- **Lead sponsor:** Tianjin Medical University Cancer Institute and Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-11-01
- **Primary completion:** 2020-01-01
- **Final completion:** 2022-08-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2019-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04137679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04137679, "Efficacy and Safety of Neo-CRT Followed Surgery Compared With Definitive CRT in Patients With Initial Unresectable ESO". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04137679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*